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SUMMARY
In choosing the best surgical treatment (total or partial laryngectomy) for patients affected by laryngeal squamous cell carcinoma (SCC), it 
is still necessary to identify a link between prognostic factors and oncological outcomes.  A retrospective analysis of clinical outcomes of 
819 patients affected by laryngeal cancer who underwent OPHL type II and III between 1995 to 2014 was carried out. Focusing on recur-
rence and its site (local, regional or distant), our cohort has been divided in two groups: patients showing recurrence (n = 108) vs those 
without recurrence (n = 711). Thirteen clinical-pathological parameters have been studied by univariate and multivariate analysis to identify 
possible correlations between recurrence and oncological outcomes (overall survival (OS), disease free survival (DFS), disease specific sur-
vival (DSS), laryngectomy free survival (LSF), laryngectomy free freedom (FFL). In multivariate analysis, we found 4 negative prognostic 
factors for recurrence: site of tumour (> supraglottic), cartilage invasion (> if present), perineural invasion (> if present) and type of OPHL 
(> in OPHL type III). The knowledge and detection of negative prognostic factors for the risk of recurrence (pN classification, cartilage 
involvement, perineural invasion, and thus the type of surgical treatment adopted) could increase the already well-established potentiality 
of OPHLs in treating cases with a safe indication after careful discussion in the tumour board.
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RIASSUNTO 
Nella scelta del trattamento chirurgico (laringectomia totale o parziale) in pazienti affetti da carcinoma laringeo, è ancora necessaria 
l’identificazione di una correlazione tra fattori prognostici e risultati oncologici. Una coorte multi-istituzionale di 819 pazienti affetti da 
carcinoma laringeo e sottoposti a laringectomia parziale orizzontale (OPHL) tipo II e tipo III dal 1995 al 2014 è stata suddivisa in base 
alla comparsa o meno di recidiva (108 vs 711) ed alla sede di ricomparsa di malattia (loco-regionale, locale, a distanza). Sono state analiz-
zate, mediante analisi uni e multivariata, tredici variabili cliniche e istologiche nei due gruppi, in relazione agli esiti oncologici (OS, DFS, 
DSS, LSF, FFL). All’analisi multivariata quattro sono risultati i fattori determinanti rischio di recidiva: sede del tumore (maggiormente 
nei tumori sopraglottici), invasione cartilaginea (maggiormente se presente), invasione perineurale (maggiormente se presente) ed il tipo 
di OPHL (maggiormente in caso di OPHL tipo III). La conoscenza  e la detezione dei fattori prognostici negativi per il rischio di recidiva 
(classificazione pN, interessamento cartilagineo, invasione perineurale e quindi trattamento chirurgico adottato) potrebbero aumentare le 
già note potenzialità delle OPHL nel trattare casi con indicazione certa dopo attenta discussione collegiale. 
PAROLE CHIAVE: Laringectomia parziale orizzontale • Laringectomia parziale sopracricoidea • Laringectomia parziale sopratracheale • 
Recidiva • Carcinoma laringeo • Analisi multivariata 
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Introduction
Nowadays, surgery can be offered to patients affected by 
laryngeal cancer as a valuable method to preserve part of 
the larynx and its functions, avoiding the negative physical 
and psychosocial impact of permanent tracheostomy  1  2. 
In the last decade, organ-sparing techniques have been 
developed and extensively used, with excellent results, 
as upfront treatment in early 3 4 and in selected more ad-
vanced stages (cT3 and cT4) 5. Different therapeutic op-
tions are now available for cT3 and cT4 larynx cancers 6 7 
but a dichotomy exists considering locally advanced tu-
mours: is the lesion amenable to partial laryngectomy or 
to total laryngectomy? During multidisciplinary discus-
sions about larynx cancer treatment, this is not a simple 
question. 
Each time, the surgeon faces the decision to attempt con-
servative treatment or to address the patient to a safer 
up-front total laryngectomy. The choice of treatment to 
recommend can be difficult to understand, especially for 
young or less experienced surgeons. In fact, if two lesions 
are at the same stage and patients are free from contrain-
dications related to general conditions, why are they se-
lected for different treatments?
This is because a clear consensus is still lacking for what 
concerns simple and objective parameters that should be 
used in the selection of patients amenable to one or the 
other technique. Although staging of laryngeal cancer has 
been considered for a long period the criterion that better 
correlates with loco-regional control and patient survival, 
prognosis is a complex phenomenon arising from tumour 
and patient characteristics, molecular biology, genetics 
and environment  8  9. However, the importance of each 
has not been unequivocally demonstrated. To complicate 
matters further, negative prognostic factors involved in 
recurrence onset are not established universally, but are 
important to discriminate the most suitable treatment for 
the patient.
The application of logistic regression models to retrospec-
tive studies allows detection and/or analysis of prognostic 
factors that are potentially useful to predict the main onco-
logic and functional outcomes. Furthermore, data emerg-
ing from large multi-institutional series of cases who were 
treated with the same protocols provide insights about the 
most controversial aspects in the treatment indications. 
In this multi-institutional retrospective study, we analysed 
a large series of locally advanced laryngeal cancer pa-
tients treated by open partial horizontal laryngectomies 
(OPHL) spurred by a dual aim: a) the identification of 
novel prognostic factors correlating with disease recur-
rence; b) improvements for more correct use of OPHL as 
a single and up-front laryngeal cancer treatment, based on 
results of the previous point. 
Patients and methods
Patients
The study was conducted retrospectively analysing medi-
cal records from 819 patients affected by laryngeal cancer 
who underwent OPHL between January 1995 and De-
cember 2014 in tertiary reference Italian hospitals: Hospi-
tal of Vittorio Veneto (Treviso), Martini Hospital (Turin), 
Candiolo Cancer Institute (Turin) and Policlinico Hospi-
tal (Modena). Patient characteristics, distribution accord-
ing to the involved laryngeal sites, as well as their pT and 
pN categories (2009 TNM classification system)  10, are 
reported in Table I. 
Inclusion criteria were histological diagnosis of glottic or 
supraglottic laryngeal squamous cell carcinoma (LSCC), 
Karnofsky index  11 higher than 80 and amenability to 
OPHL type II for advanced laryngeal cancers maintaining 
laryngeal functions  12 and type III surgeries for glottic/
transglottic cancers extending to the cricoid or to extra-
laryngeal space 1 13 14. 
Exclusion criteria were: a) purely supraglottic T3 tu-
mour with limited extension to the pre-epiglottic space 
(and therefore amenable to OPHL type I or transoral la-
ser microsurgery); b) lesions extended to base of tongue 
or pyriform sinus; c) lesions with major invasion of 
pre-epiglottic space involving the hyoid bone, involving 
the inter-arytenoid space, the posterior commissure and 
both arytenoid cartilages; d) large extralaryngeal spread 
of cancer involving thyroid gland, strap muscles, cervi-
cal skin, internal jugular vein or common carotid artery; 
e) lesions reaching the first tracheal ring; f) severe dia-
betes mellitus; g) severe chronic obstructive pulmonary 
disease; h) neurological problems impairing the ability to 
expectorate and/or swallow; and i) severe cardiac disease. 
The presence of clinically positive nodes > cN1 was not 
considered as an absolute contraindication. However, it 
should not represent a good indication for OPHL due to 
the probable need for post-operative radiotherapy (RT) 15.
One hundred and forty patients (17.1%) had already 
been treated previously for laryngeal carcinoma by CO
2
 
transoral laser surgery (61/140; 43.6%), radiation thera-
py (39/140; 27.9%), laser surgery and radiation therapy 
(11/140; 7.8%), cordectomy (21/140; 15.0%), open par-
tial laryngectomy (7/140; 5.0%), or chemotherapy (1/140; 
0.7%).
Thirteen clinical-pathological parameters are studied as 
possible negative prognostic factors: previous treatments, 
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type of surgery, tumour site, pT subcategory, pN classifi-
cation, grading, cartilage involvement, vascular invasion, 
perineural invasion, Delphian lymph node pN+, extran-
odal extension (ENE), status of margins, adjuvant treat-
ments (Table II). Age was not considered among these 
factors because elderly patients affected by laryngeal can-
cer can be treated as younger patients 16. 
Surgical procedures
Total laryngectomy and OPHL Type II are the most estab-
lished solutions for intermediate-advanced stage larynge-
al tumours affecting the glottis. OPHL Type III, instead, 
is amenable to glottic/transglottic tumours with subglottic 
extension reaching the cricoid and glottic/transglottic T4a 
lesions with extralaryngeal progression through the cau-
dal end of the thyroid cartilage and/or through the crico-
thyroid membrane 1.
According to this, after informed consent had been ob-
tained, all patients underwent OPHL types II-III  17 
with curative intent: type IIa  =  159/819 (19.4%), type 
IIa+ARY = 354/819 (43.2%), type IIb = 46/819 (5.6%), 
type IIb+ARY = 138/819 (16.9%), type IIIa = 10 (1.2%), 
type IIIa+CAU  =  99/819 (12.1%), type IIIb  =  5/819 
(0.6%), type IIIb+CAU = 8/819 (1.0%) (Table III).
Neck dissection (ND), graded according to the Ameri-
can Academy of Otolaryngology – Head and Neck Sur-
gery Foundation classification  18, was performed in 704 
patients (85.9%), and was unilateral in 606 (86.1%) and 
bilateral in 98 (13.9%) cases. ND was elective (ND lev-
els II-IV) in 634 cN0 (90.1%) and curative in 70 cN > 0 
(9.9%) patients. Level VI or unilateral paratracheal lymph 
node clearance was added in 449 (63.7%) patients. No 
ND was performed in 115 cN0 (14.1%) cases.
Adjuvant treatment
Based on pathological findings, 95 (11.6%) patients were 
subjected to adjuvant treatment. Ninety-four (99.0%) 
were subjected to radiotherapy. The indications were: 
pN>1 (60 patients - 63.8%) and/or gross extralaryngeal 
extension (34 patients - 36.2%) with or without positive 
margins. A large volume encompassing the primary site 
and all draining lymph nodes were irradiated with a dose 
of up to 54 Gy. Regions at higher risk for malignant dis-
semination received a 12 Gy boost (total, 66 Gy; range, 
62–68 Gy). Because of a higher risk of local recurrence 
[Delphian nodes pN+, pN+ with extracapsular spread 
(ECS), more extended pT4a tumours showing positive/
close margins toward pre-laryngeal tissues, perineural 
invasion, or cartilage invasion], 52/95 (55.3%) patients 
received cisplatin (100 mg/m2 on days 1, 22, and 43) con-
comitant with radiotherapy. 
The remaining patient (1.0%) was subjected to chemo-
therapy alone, due to presence of distant metastasis. 
Statistical methods
OS, DSS, DFS, FFL, LFS and laryngo-oesophageal 
dysfunction-free (LEDFS)  19 survivals were assessed by 
Kaplan-Meier curves. Log-rank (LR) and Gehan-Bres-
Table I. Epidemiologic and clinical characteristics of patients treated by OPHL in the present series (N = 819).
No of patients (%)
Age Mean ± standard deviation 60.2 ± 9.4
Range 16-87
Gender Male 755 (92.2%)
Female 64 (7.8%)
Arytenoid mobility Normal 581 (70.9%)
Impaired/fixed 238 (29.1%)
pTN (VII ed.) Glottic Supraglottic
pT2 N0 201 (31.8%) 22 (11.8%)
N1 2 (0.3%) 4 (2.2%)
N2 3 (0.5%) 4 (2.2%)
pT3 N0 291 (46.0%) 86 (46.2%)
N1 13 (2.1%) 11 (6.0%)
N2 13 (2.1%) 23 (12.4%)
pT4 N0 94 (14.7%) 27 (14.4%)
N1 10 (1.6%) 4 (2.2%)
N2 6 (0.9%) 5 (2.6%)
Total 633 (77.3%) 186 (22.7%)
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low-Wilcoxon (GBW, for early events) tests were used 
to compare Kaplan-Meier estimates among the different 
subcategories. 
The endpoints considered were obtained as the length of 
time from the date of diagnosis to: date of death (OS), 
date of death from disease (DSS), date of first recurrence 
(DFS), date of salvage laryngectomy (FFL), date of sal-
vage total laryngectomy or date of death (LFS), date of 
salvage total laryngectomy or date of tracheostomy and/
or PEG for functional reasons or date of death (LEDFS). 
Univariate regression with collinearity analysis was used 
to evaluate independent risk factors (previous treatment, 
type of surgery, tumour site, pT stage, pN stage, grad-
ing, cartilage involvement, vascular or perineural inva-
sion, Delphian lymph node pN+, ENE, status of margins, 
and adjuvant treatment). Variables were than included in 
logistic regression model. Kaplan-Meier curves, LR and 
GBW tests were performed with GraphPad Prism version 
7.0a (GraphPad Software, San Diego, CA, USA), where-
as univariate and multivariate regression analyses were 
performed with IBM® SPSS® Statistics version 24 (IBM 
Corp., Armonk, NY, USA). The incidences of relevant 
prognostic factors were analysed by a chi-squared test 
(PRIMIT-statistics for biomedical learning version 3.03). 
For all analyses, p < 0.05 was considered as the threshold 
for statistical significance.
Results 
Pathology
Pathology reports showed close margins (<  2 mm on 
the specimen side) in 43 cases of 819 (5.3%) and posi-
tive margins (negative at frozen sections on the mucosa 
taken from the remaining larynx, but positive at definitive 
histopathologic examination on specimen) in 68 cases 
(8.3%). Positive or closed margins were associated with 
more advanced pT classification in both previously treat-
Table II. Stratification of patients (N = 819) according with the clinic-path-
ological parameters evaluated as possible risk factors for development of 
recurrences.
Clinic-pathological 
parameters
Recurrences Patients
Negative Positive
Previous treatment
Positive 119 (16.7%) 21 (19.4%) 140 (17.1%)
Negative 592 (83.3%) 87 (80.6%) 679 (82.9%)
Type of surgery
OPHL Type II 620 (87.2%) 77 (71.3%) 697 (85.1%)
OPHL Type III 91 (12.8%) 31 (28.7%) 122 (14.9%)
Tumour site
Supraglottic 149 (21.0%) 32 (29.6%) 181 (22.1%)
Glottic 556 (78.2%) 73 (67.6%) 629 (76.8%)
Other 6 ( 0.8%) 3 ( 2.8%) 9 ( 1.1%)
pT stage
pT1 3 ( 0.4%) 2 ( 1.9%) 5 ( 0.6%)
pT2 217 (30.5%) 17 (15.7%) 234 (28.6%)
pT3 385 (54.1%) 51 (47.2%) 436 (53.2%)
pT4 106 (14.9%) 38 (35.2%) 144 (17.6%)
pN stage
pN0 645 (90.7%) 76 (70.4%) 721 (88.0%)
pN1 30 ( 4.2%) 13 (12.0%) 43 ( 5.3%)
pN2 36 ( 5.1%) 19 (17.6%) 55 ( 6.7%)
Grading
Basaloid 10 ( 1.4%) 3 ( 2.8%) 13 ( 1.6%)
G1 179 (25.2%) 11 (10.2%) 190 (23.2%)
G2 326 (45.9%) 45 (41.7%) 371 (45.3%)
G3 196 (27.6%) 49 (45.4%) 245 (29.9%)
Cartilage involvement
Positive 116 (16.3%) 50 (46.3%) 166 (20.3%)
Negative 595 (83.7%) 58 (53.7%) 653 (79.7%)
Vascular invasion
Positive 194 (27.3%) 43 (39.8%) 237 (28.9%)
Negative 517 (72.7%) 65 (60.2%) 582 (71.1%)
Perineural invasion
Positive 119 (16.7%) 39 (36.1%) 158 (19.3%)
Negative 592 (83.3%) 69 (63.9%) 661 (80.7%)
Delphian lymph node pN+
Positive 19 ( 2.7%) 10 ( 9.3%) 29 (3.5%)
Negative 692 (97.3%) 98 (90.7%) 790 (96.5%)
Extranodal extension
Positive 18 ( 2.5%) 11 (10.2%) 29 ( 3.5%)
Negative 693 (97.5%) 97 (89.8%) 790 (96.5%)
Status of margins
Positive 55 ( 7.7%) 13 (12.0%) 68 ( 8.3%)
Close 29 ( 4.1%) 14 (13.0%) 43 ( 5.3%)
Negative 627 (88.2%) 81 (75.0%) 708 (86.4%)
Adjuvant treatment
Positive 67 ( 9.4%) 28 (25.9%) 95 (11.6%)
Negative 644 (90.6%) 80 (74.1%) 724 (88.4%)
Table III. Treatments performed in the 819 patients.
Type of treatment N (%)
OPHL
IIa 159 (19.4%)
IIa + ARY 354 (43.2%)
IIb 46 (5.6%)
IIb + ARY 138 (16.9%)
IIIa 10 (1.2%)
IIIa + CAU 99 (12.1%)
IIIb 5 (0.6%)
IIIb + CAU 8 (1.0%)
ARY: arytenoid; CAU: crico-arytenoid unit.
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ed (p  <  0.05) and untreated (p  <  0.001) patients, while 
it correlated with the employment of the more aggres-
sive OPHL type III only in previously treated patients 
(p < 0.01).
We detected 166 patients with cartilage invasion among 
the 582 (28.5%) who are affected by T3-T4 tumours 
(categories that could have cartilage invasion as defini-
tion). In particular, we detected the following pattern of 
cartilage invasion: 86/166 (51.8%) inner cortex of thy-
roid cartilage, 59/166 (35.5%) full thickness thyroid car-
tilage, 13/166 (7.8%) cricoid cartilage and 8/166 (4.9%) 
epiglottis cartilage. Among patients who experienced a 
recurrence, 50 (46.3%) had pathologic involvement of 
cartilages, the majority (44, 88.0%) at level of the thyroid 
cartilage. Furthermore, the development of recurrences 
and crico-arytenoid fixation did not correlate with patho-
logical grading of lesions.
Finally, 746/819 patients (91.1%) had been staged as cN0. 
In contrast, 44 (5.9%) became pN+ after ND. Overall, 
lymph node metastases were detected in 98 (11.9%) pa-
tients, of whom 55 (56.1%) had multiple metastases. 
Patterns of failure
Globally, 108 (13.2%) patients developed recurrences 
within 5 years after surgery. Thirty-eight patients (35.2%) 
displayed local recurrence, 25 patients (23.1%) regional 
and 8 (7.4%) distant. Twenty (18.5%) had local and re-
gional recurrences, 6 (5.6%) were regional and distant and 
4 (3.7%) local and distant recurrences. 7 patients (6.5%) 
developed both loco-regional and distant recurrences. 
Among the 69 patients affected by local recurrence, 55 
were endolaryngeal (79.7%), 9 extralaryngeal (13.0%) 
and 5 indeterminate (7.3%). The regional recurrences 
were detected on level VI in 19/58 patients (32.8%), 
whereas it affected levels II-V in the remaining 39 cases 
(67.2%). Among the latter, 34 (87.2%) recurrences were 
detected homolaterally, 3 contralaterally (7.7%) and 2 bi-
laterally (5.1%).
Recurrences were detected equally in patients who 
received previous treatments (21/140,15.0%) or not 
(87/679, 12.8%, p  =  0.576). Furthermore, local recur-
rences displayed similar patterns between the two groups 
(p = 0.917). Otherwise, although the difference was not 
statistically significant (p = 0.065), previously treated pa-
tients seemed to have a higher incidence of regional recur-
rences at level VI (6/10, 60.0%) compared with the other 
patients (13/48, 27.1%). Furthermore, no differences 
(p = 0.241) were detected in terms of distant recurrences.
Similarly, no differences in terms of regional recurrences 
were detected between patients who underwent (47/704) 
or not (11/115, p = 0.356) ND. At any rate, among those 
who also received level VI clearance (20/449), the asso-
ciated risk was higher (p = 0.055) likely due to a more 
advanced pathology.
Survival and disease control according to different pat-
terns of failure 
Patients were followed for a minimum period of 2 years 
and a maximum period of 16.4 years. The mean and the 
median period were 5.3 and 4.8 years, respectively. Eight 
patients were lost to follow-up: 3 among recurrent pa-
tients and 5 not previously treated. 5-year survival esti-
mates are reported in Table IV. All endpoints were highly 
impaired by the onset of recurrences (p < 0.001, LR and 
GBW) compared to the non-recurring counterpart. Even 
if the majority of stratifications did not indicate significant 
differences among the different types of local recurrence, 
OS and DSS were more affected by local recurrences of 
Table IV. Five-year Kaplan–Meier estimates of assessed oncologic outcomes.
OS DSS DFS FFL LFS LEDFS
Patients with recurrent tumours
T
Endolaryngeal 57.8% 69.7% 7.8% 42.5% 33.2% 16.5%
Extralaryngeal 64.8% 88.9% 0.0% 38.1% 27.8% 0.0%
Indeterminate 28.6% 28.6% 0.0% 47.6% 28.6% 14.3%
N
Level II-V 42.5% 63.9% 5.3% 74.8% 37.1% 25.1%
Level VI 51.2% 63.3% 11.1% 59.5% 41.4% 20.8%
M
Positive 40.0% 43.6% 9.5% 81.3% 33.9% 21.8%
Patients with non-recurrent tumours 93.4% 98.9% 100% 99.8% 93.2% 93.1%
OS: overall survival; DSS: disease-specific survival; DFS: disease-free survival; FFL: freedom from laryngectomy; LFS: laryngectomy-free survival; LEDFS, laryngo-oesophageal 
dysfunction-free survival.
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undetermined origin. These were, indeed, more prone 
to induce the exitus of patients with respect to both in-
tralaryngeal (p < 0.05, OS, and p < 0.01, DSS) and clearly 
extralaryngeal (p < 0.05 OS and DSS) recurrences.
Comparing previously treated and untreated patients, 
there was no significant differences, with the exception 
of the incidence of recurrence on regional lymph node 
(p < 0.01). This was likely because previous treatment al-
ready involved this site.
Risk analysis on the development of recurrences
At univariate analysis, all variables assessed correlated 
(p < 0.05) with development of recurrences. Nevertheless, 
at logistic regression, significantly correlated variables 
were pN classification (p < 0.001), presence of cartilage 
involvement (p < 0.001), presence of perineural invasion 
(p < 0.05) and type of surgical treatment (OPHL type III, 
p < 0.05) (Table V).
The onset of recurrences was detected in the 30.6% of 
patients diagnosed with pN+ cancers and in 10.5% of 
pN0 (RR = 3.1). Similarly, the frequencies of recurrence 
were higher in patients with cartilage invasion, both the 
inner cortex or through the outer cortex, (30.1%) and/or 
perineural invasions (24.7%), compared to those without 
these aspects (8.9% RR = 3.4 and 10.4% RR = 2.4, respec-
tively). More extended OPHL type III entailed a 25.4% of 
recidivate patients, whereas the onset of recurrence after 
OPHL type II was limited to 11.0% (RR = 2.3). At further 
analysis, OPHL type III was more frequently employed 
in patients with previous treatment and in glottic tumours 
(both p < 0.001), though being responsible for a higher 
incidence of recurrences at level VI (p < 0.01).
Discussion
T and N staging are recognised as the best factor to predict 
survival of patients with laryngeal cancer 20 21 24. Notwith-
standing, prognosis is generally more complex and also 
depends on many other variables, such as age, clinical-
pathologic characteristics, surgical margin status and type 
of surgery. Some of these could be responsible of adverse 
events 22, complications or even recurrences that hamper 
survival of patients 16. Thus, the literature is rich in manu-
scripts describing demographic, clinical, pathological and 
therapeutic variables that have been evaluated as possible 
prognostic factors for local control of disease and overall 
survival in patients affected by laryngeal cancer. 
On the other hand, evaluation of prognostic factors that 
are expendable in predicting the onset of recurrences are 
not so common. The data emerging from this analysis do 
not correspond exactly to the few studies that have per-
formed appropriate statistical assessment on these factors 
and the possible inter-relationship between them 23.
Among the few, in the analysis of 253 patients affected 
glottic and supraglottic laryngeal cancer and undergo-
ing OPHL, Gallo and colleagues  20  demonstrated that 
the presence of positive surgical margin was the unique 
significant prognostic factor correlated with the onset of 
local recurrences. However, we should keep in mind that 
this was a monocentric study, homogenous regarding in-
dications and surgical techniques and no patients were 
included with previous treatment for laryngeal cancer. 
Indeed, with regards to the major differences found be-
tween the study by Gallo and coworkers  20, focused on 
the parameters influencing local control and survival after 
Table V. Analyses of factors predicting recurrence.
Variable Univariate analysis Logistic regression model
Score test P value Score test P value 
Previous treatments 0.604 0.437 0.038 0.846
Type of surgery 14.118 < 0.001 4.928 0.026
Tumour site 1.131 0.288 0.932 0.334
pT subcategory 16.389 < 0.001 0.100 0.752
pN ≥ 1 staging 15.742 < 0.001 15.643 < 0.001
Grading 6.481 0.011 1.299 0.254
Cartilage involvement 38.174 < 0.001 24.221 < 0.001
Vascular invasion 3.725 0.054 0.857 0.355
Perineural invasion 15.062 < 0.001 6.018 0.014
Delphian node pN+ 5.033 0.025 0.155 0.694
Extranodal extension 16.620 < 0.001 2.253 0.133
Status of margins 6.124 0.013 1.253 0.263
Adjuvant treatments 14.393 < 0.001 0.859 0.354
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supracricoid laryngectomy, it should be noted that neither 
T category nor positivity of resection margins correlated 
with the risk of recurrence. 
The reason may lie in the different types of surgery adopt-
ed. In addition, in order to point out the factors that under-
lie the onset of recurrences (n = 108, 13.2%) in a broader 
cohort of patients (n = 819), we analysed oncologic re-
sults. To obtain this, we subdivided patients accordingly 
to their pattern of failure. All oncologic outcomes (OS, 
DSS, DFS, FFL, LFS, and LEDFS) were significantly im-
paired by the onset of recurrences though the entity was 
similar among the different pattern on T, N and M. How-
ever, local recurrences (T) of indeterminate origin, mean-
ing an iceberg-like recurrence affecting in small part the 
remnant endolarynx, but massively the paralaryngeal tis-
sues, were more prone to induce exitus (OS and DSS) of 
patients with respect to the intralaryngeal and extralaryn-
geal ones. In fact, in these cases it is practically impossi-
ble to carry out salvage resection in free and safe margins 
because diagnosis of recurrence was often late.
Considering that, as expected, recurrent patients had 
worse prognosis than non-recurrent ones, we evaluated 
the characteristics of the two populations to detect pos-
sible risk factors. Among the 13 different variables as-
sessed, at logistic regression analysis only pN ≥ 1, carti-
lage invasion (both the inner cortex or through the outer 
cortex), perineural invasion and employment of more in-
vasive OPHL type III were directly correlated with the 
onset of recurrences. 
N classification has been often related to worse progno-
sis. In this point of view, it should not be surprising that 
patients classified as pN≥1 had a higher risk (RR = 3.1) to 
generally develop recurrences than those without lymph 
node involvement (pN0). Neck dissection was performed 
with either elective or curative purposes in the majority 
of patients (85.9%). Nevertheless, neck recurrences were 
detected in 25 of 98 (25.5%) pN+ patients, of whom 14 
(14.3%) had undergone adjuvant radiotherapy or radio-
chemotherapy, and in 33 of 721 (4.6%) pN0 patients. In-
terestingly, recurrences were predominantly at levels II-V 
in pN+ patients (88.0%), but were equally detected at both 
level VI (48.5%) and levels II-V (51.5%) in pN0 patients. 
This different distribution was likely due to the cancer lo-
calisation, as recurrence at levels II-V are more frequent 
in supraglottic tumours. In fact, lymph node relapsing 
patients were affected by supraglottic cancer in 56.0% 
of pN+ cases, if compared with the 24.2% of those pN0 
(p < 0.05). Nevertheless, no differences in terms of tumour 
classification or use of adjuvant therapy were detected be-
tween relapsing and non-relapsing pN+ patients.
In the present cohort, patients with cartilage invasion at the 
inner cortex or through the outer cortex showed a greater 
probability to develop recurrences (RR = 3.4). This phe-
nomenon is because the cartilage invasion demonstrates an 
extralaryngeal escape pathway. This aspect, if suspected 
pre-operatively, should always determine the recourse to a 
ND of the ipsilateral levels II-IV, but in particular to me-
ticulous dissection of the central compartment of the neck 
as well as strap muscles resection and dissection of the 
pre-laryngeal tissue, immediately analysed by frozen sec-
tions. Considering the pattern of failure, the involvement 
of cartilages had no effect on T and M recurrence, but sig-
nificantly correlated with that on N. Indeed, cartilage inva-
sion increased the rate of recurrences on level VI lymph 
nodes (14/50, 28.0%, p < 0.05) rather than level II-V ones 
(10/50, 20.0%, p < 0.01), compared to patients with nega-
tive cartilage (5/58, 8.6%; and 29/58, 50.0%, respectively). 
The lack of significance at logistic regression of T clas-
sification, despite being strongly related to depth of car-
tilage invasion seems plausible to us because, beyond T4 
tumours, many lesions classified as T3 had focal or multi-
focal invasion of internal lamina of thyroid cartilage. This 
phenomenon occurs more frequently in the lower aspect of 
the thyroid cartilage since the tumour often shows progres-
sion towards the crico-thyroid space. Even in the absence 
of full-thickness cartilage invasion, the behaviour of this 
subcategory of tumours, schematically represented by a 
subglottic extension more than 10 mm at the true vocal 
cord (TVC) midline, is to be considered similar to that of 
tumours staged in the upper category of T4a. Therefore, 
more cautious surgical resection should be preferred, char-
acterised by careful dissection of level VI nodes. 
For what concerns perineural invasion, although enhanc-
ing the overall risk of developing recurrences (RR = 2.4), 
the risk factor did not correlate per se with significant al-
teration of the pattern of failure. However, it is generally 
present in tumours characterised by advanced T stage and 
high histological grade classification, which are thus more 
refractory to treatments and show worse prognosis. Patients 
with perineural invasion should undergo strict follow-up to 
diagnose recurrences early. Moreover, this result gives rise 
to discussions in the tumour board about the necessity to 
treat patients affected by locally advanced tumours with ad-
juvant radiotherapy, possibly showing this negative prog-
nostic factor for loco-regional recurrence. 
Finally, regarding the type of surgery, we detected a 
higher risk of developing recurrences in cases treated by 
OPHL type III (RR = 2.3). We should keep in mind that 
supratracheal laryngectomies (OPHL type III) are gener-
ally employed in the treatment of more aggressive and 
advanced disease. Thus, more attention should be paid to 
this analysis. 
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Undoubtedly, OPHL type III extended indications of par-
tial laryngectomy in case of cancers (glottic-subglottic 
tumours, T4a tumours) that, historically, were treated by 
total laryngectomy. Nevertheless, it determines a major 
rate of close margins, negative the frozen sections when 
the sample is collected on the side of the remnant larynx, 
but positive on the side of the specimen, generally corre-
lates with a major rate of level VI lymph nodes metastasis. 
Although not mathematically, considering that the larynx 
also “accepts” minimal resection margins, this can expose 
patients to a greater number of loco-regional relapses 
(compared to those after OPHL type II) especially when 
detected as T indeterminate feature recurrences or on the 
level VI lymph nodes. Therefore, cases to be addressed to 
this surgical option must be selected very well. 
OPHLs type III are safely indicated in case of T3 tumours 
with subglottic extension preferable < 10 mm at the TVC 
midline or in case of T4a “anterior” tumour 15, because 
these patients have demonstrated good oncologic results 
with a low percentage of recurrence. On the contrary, even 
T3 or T4a “posterior” tumours, where arytenoid fixity is 
related to an infraglottic extension > 10 mm at the TVC 
midline or to a massive posterior crico-arytenoid unit in-
vasion, the tumour clearly acts aggressively as if it were 
always a T4.
OPHLs type III surgeries are therefore quite safe in first 
two cases, especially if the resection encompasses one cri-
co-arytenoid unit. In the latter conditions, the safest treat-
ment is total laryngectomy, also considering some disap-
pointing events (positive margins, level VI pN+, ENE), 
that are more frequently associated with recurrence. Only 
in the case of categorical refusal by the patient to total 
laryngectomy, after informing about the risk of giving pri-
ority to the functional outcomes rather than to oncologic 
ones, in some very selected cases it is still possible to car-
ry out an OPHL type IIIa. This option, even if not optimal, 
should be equally considered as chemoradiotherapy when 
drafting guidelines. 
Conclusions
To our knowledge, this study is the first to use logistic 
regression on a very large cohort of patients treated by 
all different types of supracricoid and supratracheal par-
tial laryngectomies (OPHL type II / III). The detection 
of clinical and pathological parameters that correlate with 
the development of recurrences (pN classification, carti-
lage involvement, perineural invasion, and thus the type 
of surgical treatment adopted) can be useful to reduce the 
event rate. Therefore, we suggest serious discussion in the 
multidisciplinary tumour board regarding the possible in-
dications of OPHL, rather than resorting to a simpler and 
safer total laryngectomy or, alternatively, to concomitant 
chemoradiation-therapy, especially in cases where addi-
tional risk factors are present, such as the exiguity of sur-
gical margins and use of more extensive surgeries.
In this delicate process, the patient and his/her caregiv-
ers also are involved, being important actors. With due 
delicacy, also analysing data from large series, they must 
be faced with and helped in choosing among the difficult 
dichotomy to give greater emphasis to a “quoad vitam” 
rather than to a “quoad functionem” prognosis.
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